BMS-505130 (fumarate)

BMS-505130 fumarate is a potent, selective and orally active serotonin transport inhibitor with a Ki for binding to the serotonin transporter of 0.18 nM (Ki for norepinephrine and dopamine transporters of 4.6 and 2.1 μM, respectively) . BMS-505130 fumarate can be used for the research of neurological disease, such as depression[1].

Product Specifications

CAS Number

[859230-84-5]

UNSPSC

12352005

Target

5-HT Receptor

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Smiles

O=C(O)/C=C\C(O)=O.CN(C)C[C@@H]1[C@@H](C2=CNC3=CC=C(C#N)C=C23)C1

Molecular Formula

C19H21N3O4

Molecular Weight

355.39

References & Citations

[1]Taber MT, et al. Neurochemical, pharmacokinetic, and behavioral effects of the novel selective serotonin reuptake inhibitor BMS-505130. Pharmacol Biochem Behav. 2005 Mar;80 (3) :521-8.